PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review.
Lars J PetersenHelle D ZachoPublished in: Cancer imaging : the official publication of the International Cancer Imaging Society (2020)
PSMA PET showed promising diagnostic accuracy for primary lymph node staging with pathology as reference. Recommendation for PSMA PET for high-risk patients in clinical guidelines should be supported by confirmatory, prospective trials with patient-relevant outcomes.
Keyphrases
- pet ct
- lymph node
- pet imaging
- prostate cancer
- systematic review
- positron emission tomography
- end stage renal disease
- neoadjuvant chemotherapy
- ejection fraction
- chronic kidney disease
- sentinel lymph node
- meta analyses
- radical prostatectomy
- peritoneal dialysis
- computed tomography
- case report
- metabolic syndrome
- radiation therapy
- squamous cell carcinoma
- adipose tissue
- insulin resistance
- rectal cancer